psychedelics investing Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
psychedelics investing Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
psychedelics investing Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
psychedelics investing Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
psychedelics investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
Standard Uranium Initiates 2026 Drill Program at the Davidson River Uranium Project, Southwest Athabasca Basin
Nuvau Minerals commences PEA study to advance Matagami restart strategy, which includes a fully permitted critical metals mine
Pinnacle Receives More Positive Results from Second Round of Scoping Metallurgical Tests at El Potrero with Average Gold Recovery of 97.8% for the Main Dos de Mayo Vein
